Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Gliosarcoma 2Glioblastoma 2Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Mesothelioma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Glioma 1Enteropathy-Associated T-Cell Lymphoma 1Brain Neoplasms 1

Interventions

fludarabine phosphate 15Cyclophosphamide 13Whole-Body Irradiation 12Peripheral Blood Stem Cell Transplantation 12Tacrolimus 10Etoposide 10Rituximab 8Mycophenolic Acid 8Methotrexate 6Melphalan 6Cyclosporine 6Busulfan 6Antilymphocyte Serum 6Vorinostat 4Sirolimus 4Prednisone 4Lenalidomide 4Immunohistochemistry 4Gene Expression Profiling 4Carboplatin 4Vincristine 3Microarray Analysis 3Gemcitabine 3Everolimus 3Doxorubicin 3Dexamethasone 3Brentuximab Vedotin 3Alemtuzumab 310-propargyl-10-deazaaminopterin 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Immunoblastic Lymphadenopathy × Automobiles × Clear all
NCT03049449 2023-01-18

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
26 enrolled 19 charts
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡